Latin America represents an emerging hub for neuroscience research and biotechnology development, with Brazil leading regional efforts in Alzheimer's disease, Parkinson's disease, and related neurodegenerative disorders. This page documents companies, academic institutions, and research initiatives focused on neurodegeneration in the region.
Overview
flowchart TD
companies_latin_american_neuro["Latin American Neurodegeneration Biotech Compani"]
style companies_latin_american_neuro fill:#4fc3f7,stroke:#333,color:#000
companies_latin_amer_0["Brazil"]
companies_latin_american_neuro -->|"includes"| companies_latin_amer_0
style companies_latin_amer_0 fill:#81c784,stroke:#333,color:#000
companies_latin_amer_1["Biotechnology Companies"]
companies_latin_american_neuro -->|"includes"| companies_latin_amer_1
style companies_latin_amer_1 fill:#ef5350,stroke:#333,color:#000
companies_latin_amer_2["Academic Institutions"]
companies_latin_american_neuro -->|"includes"| companies_latin_amer_2
style companies_latin_amer_2 fill:#ffd54f,stroke:#333,color:#000
companies_latin_amer_3["Research Initiatives"]
companies_latin_american_neuro -->|"includes"| companies_latin_amer_3
style companies_latin_amer_3 fill:#ce93d8,stroke:#333,color:#000
companies_latin_amer_4["Argentina"]
companies_latin_american_neuro -->|"includes"| companies_latin_amer_4
style companies_latin_amer_4 fill:#4fc3f7,stroke:#333,color:#000
The Latin American biotech landscape in neurodegeneration is characterized by:
...Latin America represents an emerging hub for neuroscience research and biotechnology development, with Brazil leading regional efforts in Alzheimer's disease, Parkinson's disease, and related neurodegenerative disorders. This page documents companies, academic institutions, and research initiatives focused on neurodegeneration in the region.
Overview
Mermaid diagram (expand to render)
The Latin American biotech landscape in neurodegeneration is characterized by:
- Growing academic research infrastructure
- Government funding through national science agencies
- International collaborations with US and European partners
- Unique population genetics offering research advantages
The region has approximately 15 million people living with Alzheimer's disease and Parkinson's disease combined, creating significant demand for local research and treatment development [1]. Governments across Latin America have increased funding for neuroscience research, with Brazil's São Paulo Research Foundation (FAPESP) being a major supporter of neurodegeneration research [2].
Brazil
Biotechnology Companies
Recepta Biopharma
Location: São Paulo, Brazil
Focus: Oncology and neuroscience
Recepta Biopharma is a Brazilian biotech developing antibody-based therapies. The company has expanded into neuroscience research, focusing on neuroinflammatory pathways in Alzheimer's disease.
- Pipeline: Monoclonal antibodies for neurodegenerative targets
- Research: Neuroinflammation modulation
- Status: Pre-clinical to Phase I
Aché Laboratórios
Location: Guarulhos, São Paulo
Focus: Pharmaceutical development
Aché is one of Brazil's largest pharmaceutical companies with a growing neuroscience division. The company develops treatments for neurological disorders and collaborates with academic institutions on neurodegeneration research.
- Focus: CNS drug development
- Partnerships: University of São Paulo, UNICAMP
- Pipeline: Generic and novel CNS therapeutics
Eurofarma
Location: São Paulo, Brazil
Focus: Generic pharmaceuticals and innovation
Eurofarma has expanded into specialty pharmaceuticals, including CNS drugs. The company invests in research on neurodegenerative disease treatments.
- Focus: Generic CNS medications
- Research: Parkinson's disease treatments
- Pipeline: Levodopa formulations, dopamine agonists
Bergamo
Location: São Paulo, Brazil
Focus: Pharmaceutical research
Bergamo participates in neuroscience research collaborations focusing on neuroprotective compounds.
- Focus: Neuroprotective agents
- Research: Mitochondrial function in PD
Academic Institutions
University of São Paulo (USP)
Location: São Paulo, Brazil
USP is Brazil's leading research university with significant neuroscience programs:
- Institute of Biomedical Sciences (ICB): Neurobiology research
- School of Medicine: Clinical research in neurology
- Key Research: [Alpha-synuclein](/proteins/alpha-synuclein) aggregation, neuroinflammation, [amyloid-beta](/proteins/amyloid-beta) clearance
The USP Memory Clinic conducts clinical trials for Alzheimer's disease treatments and maintains one of the largest AD patient registries in Latin America [3].
UNICAMP (University of Campinas)
Location: Campinas, São Paulo, Brazil
UNICAMP is a leading research university with strong neuroscience programs:
- Brazilian Brain Institute: Neuroscience research
- Key Research: Parkinson's disease biomarkers, stem cell therapy
- Clinical: Movement disorders clinic
The university's stem cell research program has shown promising results in preclinical models of Parkinson's disease [4].
Federal University of Rio de Janeiro (UFRJ)
Location: Rio de Janeiro, Brazil
UFRJ conducts significant neuroscience research:
- Institute of Biology: Neurodegeneration mechanisms
- Key Research: Mitochondrial dysfunction in PD, neuroinflammation
- Focus: Molecular mechanisms of neurodegeneration
Federal University of São Paulo (UNIFESP)
Location: São Paulo, Brazil
UNIFESP is specialized in health sciences:
- Neurology Department: Clinical research
- Key Research: Cognitive impairment, dementia epidemiology
- Clinical Trials: AD and PD therapeutic trials
Research Initiatives
Brazilian Institute of Neuroscience (IBN)
The IBN coordinates national neuroscience research efforts, including:
- [Neurodegeneration](/diseases/neurodegeneration) research networks
- Training programs
- International collaborations
- Annual neuroscience conference
FAPESP Research Programs
The São Paulo Research Foundation funds multiple neurodegeneration research programs:
- Regular research grants
- Young investigator awards
- International collaboration grants
Argentina
Biotechnology Companies
Sinergium Biotech
Location: Buenos Aires, Argentina
Focus: Vaccine and biotech development
Sinergium has expanded beyond vaccines into neuroscience research, focusing on immunological approaches to neurodegenerative diseases.
- Focus: Neuroimmunology
- Research: Alzheimer's disease immunotherapy
- Pipeline: Antibody-based therapies
Gador
Location: Buenos Aires, Argentina
Focus: Pharmaceutical development
Gador has a neuroscience division focused on CNS disorders:
- Focus: Alzheimer's disease treatments
- Research: [Cholinesterase inhibitors](/entities/cholinesterase-inhibitors)
- Partnerships: Local universities
Academic Institutions
University of Buenos Aires (UBA)
Location: Buenos Aires, Argentina
UBA is Argentina's leading research university:
- Faculty of Medicine: Neurology research
- Key Research: Parkinson's disease clinical studies, movement disorders
The university operates the Institute of Neurosciences that conducts both basic and clinical research on neurodegenerative diseases [5].
National University of La Plata
Location: La Plata, Argentina
- Key Research: Neurobiology of aging
- Focus: Experimental models of neurodegeneration
Mexico
Biotechnology Companies
Probiosfera
Location: Mexico City, Mexico
Focus: Biotherapeutics
Probiosfera develops biological products with applications in neuroscience, focusing on regenerative medicine approaches.
- Focus: Cell therapy for neurodegeneration
- Research: Stem cell treatments
Landsteiner Scientific
Location: Mexico City, Mexico
Focus: Pharmaceutical research
Landsteiner develops treatments for CNS disorders:
- Focus: Generic CNS medications
- Research: Alzheimer's disease therapies
Academic Institutions
National Autonomous University of Mexico (UNAM)
Location: Mexico City, Mexico
UNAM is Mexico's leading research institution:
- Institute of Physiology: Neuroscience research
- Key Research: Neuroprotection, stroke, neuroinflammation
- Programs: Graduate training in neuroscience
Instituto Nacional de Neurología
Location: Mexico City, Mexico
Mexico's premier neurology research hospital:
- Clinical Research: Alzheimer's and Parkinson's disease
- Patient Care: Comprehensive movement disorders clinic
- Trials: International clinical trial participation
Chile
Biotechnology Companies
Genzen
Location: Santiago, Chile
Focus: CNS drug development
Genzen is a Chilean biotech developing treatments for CNS disorders, including Alzheimer's and Parkinson's disease.
- Pipeline: Small molecule therapeutics
- Focus: Neurotrophic factors
- Research: BDNF mimetics
Savar
Location: Santiago, Chile
Focus: Biotech development
Savar works on biological therapies with applications in neurodegeneration:
- Focus: Protein therapeutics
- Research: Neuroprotective compounds
Academic Institutions
University of Chile
Location: Santiago, Chile
University of Chile leads neuroscience research in Chile:
- Faculty of Medicine: Neurology research
- Key Research: Neurodegeneration mechanisms, neuropharmacology
- Clinical: Movement disorders program
Pontifical Catholic University of Chile
Location: Santiago, Chile
- Key Research: Aging and neurodegeneration
- Focus: Biomarker research
Colombia
Research Institutions
Universidad de los Andes
Location: Bogotá, Colombia
- Neuroscience research: Alzheimer's disease epidemiology
- Population genetics: Unique Colombian populations for research
The university studies the Colombian paisa population, which has a high prevalence of early-onset Alzheimer's due to a specific mutation [6].
Colombian Neurological Institute
Location: Bogotá, Colombia
- Clinical research in Parkinson's disease
- Patient registries and clinical trials
- Training programs for neurologists
Universidad Nacional de Colombia
Location: Bogotá, Colombia
- Key Research: Neurodegeneration mechanisms
- Focus: Cellular models of PD
Regional Collaborations
Latin American Brain Research Network (LABRN)
The LABRN coordinates neuroscience research across Latin America:
- Multi-site clinical studies
- Data sharing infrastructure
- Training exchange programs
- Joint research grants
International Partnerships
Latin American institutions collaborate with:
- Michael J. Fox Foundation [7]
- [Alzheimer](/diseases/alzheimers-disease)'s Association [8]
- European research consortia
- NIH-funded research programs
Challenges and Opportunities
Challenges
- Funding: Limited venture capital compared to US/Europe
- Infrastructure: Variable research infrastructure across countries
- Regulatory: Complex regulatory environments for clinical trials
- Talent Retention: Brain drain to North American and European institutions
Opportunities
- Population Genetics: Unique founder mutations and populations
- Clinical Trials: Large, treatment-naive patient populations
- Cost Advantages: Competitive costs for clinical research
- Growing Investment: Increasing domestic and international investment
Future Directions
The Latin American neurodegeneration research sector is poised for significant growth. Key areas of focus include:
- Gene Therapy: Development of AAV-based therapies tailored to Latin American populations
- Biomarker Development: Identification of novel biomarkers for early detection
- Digital Health: Telemedicine and remote monitoring solutions
- Precision Medicine: Genetic screening and personalized treatment approaches
Regional initiatives such as the Latin American Alzheimer's Disease Initiative (LADSI) are working to establish standardized protocols and facilitate international collaboration. These efforts aim to position Latin America as a key player in global neurodegeneration research.
Cross-Linking
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Biotechnology Companies](/companies/biotechnology-companies)
- [Brazil](/countries/brazil)
- [Academic Institutions](/institutions/academic-institutions)
See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
- [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)
References
[Alzheimer's Disease International - Latin America Report](https://www.alzint.org/about/dementia-statistics/)
[FAPESP Neuroscience Research Programs](https://fapesp.br/)
[USP Memory Clinic and Clinical Trials](https://www.fm.usp.br/)
[Brazilian Journal of Medical and Biological Research - Stem Cell Therapy](https://pubmed.ncbi.nlm.nih.gov/23950303/)
[UBA Institute of Neurosciences](https://www.uba.ar/)
[Paisa Mutation - Early Onset Alzheimer's](https://pubmed.ncbi.nlm.nih.gov/12522768/)
[Michael J. Fox Foundation - Latin American Programs](https://www.michaeljfox.org/)
[Alzheimer's Association - International Research](https://www.alz.org/)